Chengyi Sun
Impact in
- Aging top 10%
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Cancer, Hypoxia, and Metabolism 3
- MicroRNA in disease regulation 2
-
- Muscle Physiology and Disorders 7
- RNA modifications and cancer 4
- RNA Research and Splicing 3
- Co-authors
- Douglas P. MillayMichael J. PetranyJianxin JiangLorin E. OlsonWilliam L. BerryChao YuCasey O. SwobodaMatthew T. Weirauch
- Journals
- Nature Communications (3 papers)Tumor Biology (3 papers)Cancer Letters (2 papers)Nanomedicine (1 paper)PLoS Genetics (1 paper)
- Partner nations
- ChinaUnited StatesNorway
In The Last Decade
Chengyi Sun
22 papers receiving 884 citations
Peers
Comparison fields: 5 of 87
- Aging 24
- Cancer Research 141
- Molecular Biology 587
- Physiology 197
- Complementary and alternative medicine 58
Countries citing papers authored by Chengyi Sun
This map shows the geographic impact of Chengyi Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengyi Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengyi Sun more than expected).
Fields of papers citing papers by Chengyi Sun
This network shows the impact of papers produced by Chengyi Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengyi Sun. The network helps show where Chengyi Sun may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Chengyi Sun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 7 | |
| 3 | 2023 | 8 | |
| 4 | 2021 | 15 | |
| 5 | 2021 | 45 | |
| 6 | 2020 | 212 | |
| 7 | 2020 | 46 | |
| 8 | 2020 | 2 | |
| 9 | 2019 | 79 | |
| 10 | 2018 | 5 | |
| 11 | 2018 | 28 | |
| 12 | 2017 | 30 | |
| 13 | 2016 | 27 | |
| 14 | 2016 | 7 | |
| 15 | 2015 | 46 | |
| 16 | 2015 | 44 | |
| 17 | 2015 | 5 | |
| 18 | 2014 | 59 | |
| 19 | 2014 | 91 | |
| 20 | 2014 | 37 |
About Chengyi Sun
Chengyi Sun is a scholar working on Cancer Research, Molecular Biology, Oncology, Physiology and Biomaterials, having authored 24 papers that have together received 888 indexed citations. Recurring topics across this work include Muscle Physiology and Disorders (7 papers), RNA modifications and cancer (4 papers), Cancer, Hypoxia, and Metabolism (3 papers), Pancreatic and Hepatic Oncology Research (3 papers), RNA Research and Splicing (3 papers), MicroRNA in disease regulation (2 papers), Adipose Tissue and Metabolism (2 papers) and Adipokines, Inflammation, and Metabolic Diseases (2 papers). The work is most often cited by research in Aging (24 citations), Cancer Research (141 citations), Molecular Biology (587 citations), Physiology (197 citations) and Complementary and alternative medicine (58 citations). Chengyi Sun has collaborated with scholars based in China, United States and Norway. Frequent co-authors include Douglas P. Millay, Michael J. Petrany, Jianxin Jiang, Lorin E. Olson, William L. Berry, Chao Yu, Casey O. Swoboda, Matthew T. Weirauch, Xiaoting Chen and Nathan Salomonis. Their work appears in journals such as Nature Communications, Tumor Biology, Cancer Letters, Nanomedicine and PLoS Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.